Trials / Conditions / HER-2 Positive Gastric Cancer
HER-2 Positive Gastric Cancer
5 registered clinical trials studyying HER-2 Positive Gastric Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | A Phase 1b/2 Clinical Trial Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AUR103 NCT07040059 | Aurigene Discovery Technologies Limited | Phase 1 / Phase 2 |
| Unknown | Herzuma-capecitabine/Cisplatin for Gastric Cancer NCT03588533 | Sung Yong Oh | Phase 2 |
| Withdrawn | Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment NCT02274012 | Columbia University | Phase 2 |
| Unknown | Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver NCT02380131 | Hebei Medical University | Phase 4 |
| Completed | Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(A NCT01396707 | Asan Medical Center | Phase 2 |